Search Results:

Author(s): Susi Ari Kristina, Tri Murti Andayani, Galih Putri Wulandari

DOI: 10.5958/0974-360X.2020.00089.X

Views: 17 (pdf),       1132 (html)

Access: Open Access

Cite: Susi Ari Kristina, Tri Murti Andayani, Galih Putri Wulandari. A Systematic Review of the Direct and Indirect Costs among Tuberculosis Patients. Research J. Pharm. and Tech. 2020; 13(1): 456-460. doi: 10.5958/0974-360X.2020.00089.X


Read More

Author(s): Seftika Sari, Tri Murti Andayani, Dwi Endarti, Kartika Widayati

DOI: 10.5958/0974-360X.2020.00086.4

Views: 29 (pdf),       849 (html)

Access: Open Access

Cite: Seftika Sari, Tri Murti Andayani, Dwi Endarti, Kartika Widayati. Health-Related Quality of Life in Non-Small Cell Lung Cancer (NSCLC) Patients with Mutation of Epidermal Growth Factor Receptor (EGFR) in Indonesia. Research J. Pharm. and Tech. 2020; 13(1):443-447. doi: 10.5958/0974-360X.2020.00086.4


Read More

Author(s): Seftika Sari, Tri Murti Andayani, Dwi Endarti, Kartika Widayati

DOI: 10.52711/0974-360X.2022.00267

Views: 0 (pdf),       309 (html)

Access: Closed Access

Cite: Seftika Sari, Tri Murti Andayani, Dwi Endarti, Kartika Widayati. Cost-Effectiveness Analysis of Afatinib versus Gefitinib in Non-small Cell Lung Cancer (NSCLC) with Epidermal Growth Factor Receptor (EGFR) Mutation in Indonesia: Observational studies with Retrospectives. Research Journal of Pharmacy and Technology. 2022; 15(4):1598-2. doi: 10.52711/0974-360X.2022.00267


Read More

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available